HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Marchese Selected Research

Vaccines

3/2024Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia Marchese Research Topics

Disease

3COVID-19
01/2024 - 01/2022
2Neoplasms (Cancer)
07/2018 - 01/2018
1Infections
03/2024
1Hepatoblastoma
10/2018
1Prostatic Neoplasms (Prostate Cancer)
07/2018
1Kidney Neoplasms (Kidney Cancer)
07/2018

Drug/Important Bio-Agent (IBA)

2Messenger RNA (mRNA)IBA
03/2024 - 01/2022
2COVID-19 VaccinesIBA
07/2022 - 01/2022
2Aflatoxin B1 (Aflatoxin B)IBA
10/2018 - 01/2018
2MicroRNAs (MicroRNA)IBA
07/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
07/2018 - 01/2018
1InterferonsIBA
03/2024
1AntibodiesIBA
03/2024
1VaccinesIBA
03/2024
1Monoclonal AntibodiesIBA
01/2024
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2022
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2022
1Neutralizing AntibodiesIBA
01/2022
1AflatoxinsIBA
10/2018
1Aflatoxin M1 (Aflatoxin M)IBA
10/2018
1Arsenicals (Arsenic Compounds)IBA
07/2018
1ArsenicIBA
07/2018
1CarcinogensIBA
01/2018
1DNA AdductsIBA
01/2018